[1] Chepeleva E V.Cell Therapy in the Treatment of Coronary Heart Disease[J]. International Journal of Molecular Sciences, 2023,24(23). [2] 中国血脂管理指南修订联合专家委员会, 王增武, 李建军, 等. 中国血脂管理指南(基层版2024年)[J]. 中国全科医学, 2024,27(20):2429-2436. [3] Ron C H, Christie M B.Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation[J]. Clinical chemistry, 2020,67(1):143-153. [4] 吴黎黎, 任鹏, 章宝芝, 等. 非高密度脂蛋白胆固醇和残粒脂蛋白胆固醇对急性心肌梗死的预测价值研究[J]. 中国心血管病研究, 2025,23(7):595-602. [5] David A M.The Fourth Universal Definition of Myocardial Infarction and the Emerging Importance of Myocardial Injury[J]. Circulation, 2020,141(3):172-175. [6] 李延兵. 2024年美国糖尿病学会《糖尿病诊疗标准》解读——糖尿病诊断和分型(J). 诊断学理论与实践, 2024,23(05):467-473. [7] 颜流霞, 厚磊, 蔡小宁, 等. 2015-2019年中国居民急性心肌梗死发病和死亡特征分析(J). 中国循环杂志, 2024,39(10):968-975. [8] Chukwuka E, Dependable C A, Tochi C E, et al.Comprehensive review of ST-segment elevation myocardial infarction: Understanding pathophysiology, diagnostic strategies, and current treatment approaches[J]. Medicine, 2023,102(43):e35687. [9] Loukianos S R, Iosif X, Emmanouil S B, et al.Causes, Angiographic Characteristics, and Management of Premature Myocardial Infarction: JACC State-of-the-Art Review[J]. Journal of the American College of Cardiology, 2022,79(24):2431-2449. [10] 张丽沙, 吴寿岭, 邵郅强, 等. 非高密度脂蛋白胆固醇对绝经后女性心血管疾病的影响[J]. 中国循环杂志, 2024,39(1):61-67. [11] Guo L, Chen Y, Lin Q, et al.Non-HDL-C is more stable than LDL-C in assessing the percent attainment of non-fasting lipid for coronary heart disease patients[J]. Frontiers in Cardiovascular Medicine, 2021,8:649181. [12] Wongcharoen W, Sutthiwutthichai S, Gunaparn S, et al.Is non-HDL-cholesterol a better predictor of long-term outcome in patients after acute myocardial infarction compared to LDL-cholesterol?: a retrospective study[J]. BMC Cardiovascular Disorders, 2017,17:1-7. [13] Tian X, Zuo Y, Chen S, et al.Association of changes in lipids with risk of myocardial infarction among people without lipid-lowering therapy[J]. Atherosclerosis, 2020,301(prepublish):69-78. [14] Huan H, Ami F, Toshitaka Y, et al.Non-High-Density Lipoprotein Cholesterol and Risk of Cardiovascular disease: the Japan Epidemiology Collaboration on Occupational Health Study.[J]. Journal of atherosclerosis and thrombosis, 2022, 29(9):1295-1306. [15] Meissner J, Irfan A, Twerenbold R, et al.Use of Neutrophil Count in Early Diagnosis and Risk Stratification of AMI[J]. The American Journal of Medicine, 2010,124(6):534-542. [16] Yuan H J, Yu Y D, Liu W W, et al.Identification of neutrophil extracellular traps-related genes for the diagnosis of acute myocardial infarction based on bioinformatics and experimental verification[J]. Journal of Inflammation, 2025,22(1):35. [17] Peiseler M, Kubes P.More friend than foe: the emerging role of neutrophils in tissue repair[J]. Journal of Clinical Investigation, 2019,129(7):2629-2639. [18] 张天行, 冯淑惠, 张豪, 等. 新型炎症标志物对急性心肌梗死院内死亡的预测价值[J]. 中国心血管病研究, 2024,22(7):629-634. [19] 方颖慧, 谭利利, 吕良缘, 等. 中性粒细胞和血清IL-6水平对急性心肌梗死的诊断价值研究[J]. 婚育与健康, 2024,30(6):25-27. [20] Fang C, Chen Z, Zhang J, et al.The predictive value of neutrophil-lymphocyte ratio combined with the Global Registry of Acute Coronary Events score for inhospital adverse cardiovascular events in patients with acute ST-elevation myocardial infarction.[J]. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 2024,29:41. [21] 苏洁, 王书伟, 马维东, 等. 超声心动图联合sST2、sTREM-1在急性ST段抬高型心肌梗死诊断中的临床价值[J]. 检验医学与临床, 2024,21(17):2492-2496. |